The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 161.50
Bid: 161.00
Ask: 161.50
Change: -0.25 (-0.15%)
Spread: 0.50 (0.311%)
Open: 161.50
High: 161.50
Low: 161.50
Prev. Close: 161.50
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

24 Nov 2022 07:00

RNS Number : 3939H
TClarke PLC
24 November 2022
 

24 November 2022

 

TClarke plc

 

TRADING UPDATE

 

TClarke plc ("the Group"), the Building Services Group, today provides an update on current trading and on the outlook for the financial year ending 31 December 2022.

 

Group performance and outlook

 

Since release of the Group's half year results on 14 July 2022, trading across the Group has been strong. Our high-quality secured order book continues to provide good forward visibility, despite a challenging market backdrop stemming from UK political instability, increased general market uncertainty, continued supply chain challenges, inflationary pressures and rising interest rates.

 

We are pleased to report that the Group's revenues for the full year ending 31 December are expected to be in the region of £410 million; with some £40m of revenue previously expected to be delivered in 2022 now being reprogrammed into 2023.

 

2022 is expected to be the first time Group revenues have exceeded £400 million. Operating margins (EBIT) are anticipated to be circa 2.8%.

As a result of this strong performance, the Group's earnings per share are expected to rise by approximately 27% in 2022 when compared to the prior year.

The Group remains on track to deliver £500m revenues in 2023.

Group secured workload

Looking forward, the Group has a balanced and diverse high‐quality order book. This is testament to the strength of our reputation for delivery and the durability of our long-standing client relationships.

The total secured order book for the Group at 31 October 2022 was £545m, up from the year end position of £534m at 31 December 2021 and with £384m already secured for 2023. Encouragingly this is spread across a diverse range of clients in different sectors across all our UK businesses.

Beyond what has already been secured, the Group continues to enjoy many opportunities across all its core market sectors. We are currently tendering in excess of £1bn of opportunities and are expecting decisions on approximately £500m of tendered projects by early 2023.

 

Balance sheet

The Group's balance sheet remains strong and, in what is accepted is a challenging trading environment, the strength of the Company's balance sheet creates a significant competitive advantage.

The average month end net cash for the period from 1 January 2022 to 31 October 2022 was £2 million. In addition, the Group has access to bank facilities of £30 million comprising an RCF facility of £25 million maturing in August 2026 and a £5 million overdraft facility.

Many of our clients demand performance bonds to be in place as part of the contract requirements. Due to the strength of its balance sheet TClarke has at its disposal £65m of bonding capacity; one of the largest bonding capacities when compared to our recognised peer group.

Mark Lawrence, Chief Executive, said:

"The Group is trading well, and I am proud of the performance we are delivering. 

As we approach the end of the year, I expect to be reporting that 2022 will have been a great year for TClarke. Our teams across the country are doing a fantastic job in continuing to win and deliver record volumes of high quality work, in spite of the challenging economic environment. We remain on track to deliver our strategic target of £500m revenue in 2023."

 

-ends-

 

For further information contact:

 

TClarke plc

Mark Lawrence

Group Chief Executive

Trevor Mitchell

Finance Director

Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Ben Jeynes (Corporate Finance)

Alex Pollen (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGBUGUPPGCW
Date   Source Headline
26th Apr 20241:28 pmPRNForm 8.3 - TClarke Plc
26th Apr 202410:09 amRNSForm 8.5 (EPT/NON-RI) - TClarke PLC
25th Apr 20241:56 pmPRNForm 8.3 - TClarke Plc
25th Apr 202411:52 amRNSForm 8.3 - TClarke PLC
25th Apr 20249:18 amRNSForm 8 (OPD) - TClarke plc
24th Apr 20247:21 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
19th Apr 20241:21 pmPRNForm 8.3 - TClarke Plc
18th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
18th Apr 20247:00 amRNSForm 8.1: Regent Acquisitions Limited
17th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
17th Apr 20243:03 pmGNWForm 8.3 - [TCLARKE PLC - 16 04 2024] - (CGAML)
17th Apr 202412:57 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Opening Position Disclosure Re: Clarke (T.) PLC
17th Apr 20249:47 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20244:36 pmRNSWider Regent Group Interests in TClarke Shares
16th Apr 20247:00 amRNSRevised Dividend Timetable
16th Apr 20247:00 amRNSRecommended Cash Acquisition of TClarke plc
9th Apr 20241:41 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:34 pmRNSTR-1 Notification of Holdings
27th Mar 20242:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSBlock listing Interim Review
30th Nov 20237:00 amRNSTrading Update
24th Oct 202310:21 amRNSChange of Corporate Broker
27th Jul 20234:24 pmRNSTR-1: Notification of Change of Holding
24th Jul 20235:43 pmRNSUpdate on Admission
24th Jul 20233:32 pmRNSTR-1: Notification of Change of Holding
24th Jul 202311:48 amRNSResult of GM & Total Voting Rights
13th Jul 20231:23 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHalf-year Report
6th Jul 20237:00 amRNSPlacing and Notice of GM
6th Jul 20237:00 amRNSTrading Statement
4th Jul 20237:00 amRNSBlock listing Interim Review
10th May 202311:31 amRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.